What is the treatment of Zhuhai Schwartz Pharmaceutical? Do you know any enthusiastic expert friends? I will graduate soon. Study medicine. . . .

UCB was founded in 1928, headquartered in Brussels, Belgium, with two R&D centers in Slough and Cambridge, London, England. In the 80 years of development, Youshibi Pharmaceutical Company is committed to providing more innovative treatment methods for critically ill patients and benefiting mankind. Ubisoft operates in more than 40 countries around the world and has nearly 8,500 employees. In 20 10, the global sales revenue was 3.2 billion euros. With the continuous expansion of business, in May 2004, Youshibi Pharmaceutical completed the acquisition of Cell Technology Company, a British biopharmaceutical company. On September 1 day, 2007, the global merger and acquisition of Schwartz Pharmaceutical Group in Germany was completed. So far, Youshibi Pharmaceutical Company has successfully achieved the strategic positioning of the world's leading biopharmaceutical company.

The institutions of Youshibi Pharmaceutical in China include Youshibi Trading (Shanghai) Co., Ltd. and Zhuhai Schwartz Pharmaceutical Co., Ltd., which have businesses all over the country, and their products involve central nervous system diseases, allergic diseases, cardiovascular diseases, anemia and pain treatment.

Innovation, development, honesty, responsibility, care, tolerance and performance are the values that Youshibi Pharmaceutical Company always follows.

Facing the future, Belgium Youshibi Pharmaceutical Co., Ltd. will, as always, adhere to the unique values and corporate culture of performance, responsibility, honesty, tolerance, care, pioneering and innovation, and will build a global biomedical leader, with the primary task of bringing experts and new drugs to patients who treat various serious diseases.

Good company, with sales company in Shanghai, is developing well, and more pharmaceutical companies will be stationed in Zhuhai in the future.